Runx2 represses myocardin-mediated differentiation and facilitates osteogenic conversion of vascular smooth muscle cells.
about
Olfactomedin 2, a novel regulator for transforming growth factor-β-induced smooth muscle differentiation of human embryonic stem cell-derived mesenchymal cellsArterial calcification in chronic kidney disease: key roles for calcium and phosphateRunx2/Cbfa1, but not loss of myocardin, is required for smooth muscle cell lineage reprogramming toward osteochondrogenesis.Lyso-phosphatidylcholine induces osteogenic gene expression and phenotype in vascular smooth muscle cells.Activation and repression of cellular immediate early genes by serum response factor cofactors.Ghrelin attenuates the osteoblastic differentiation of vascular smooth muscle cells through the ERK pathway.Vascular calcification is coupled with phenotypic conversion of vascular smooth muscle cells through Klf5-mediated transactivation of the Runx2 promoter.Runx2 Expression in Smooth Muscle Cells Is Required for Arterial Medial Calcification in Mice.Transforming growth factor-β1-induced transcript 1 protein, a novel marker for smooth muscle contractile phenotype, is regulated by serum response factor/myocardin proteinA limb-girdle myopathy phenotype of RUNX2 mutation in a patient with cleidocranial dysplasia: a case study and literature reviewSOX9 and myocardin counteract each other in regulating vascular smooth muscle cell differentiation.Computational segmentation of collagen fibers in bone matrix indicates bone quality in ovariectomized rat spine.Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling.Smooth muscle cell-specific runx2 deficiency inhibits vascular calcification.Yap/Taz transcriptional activity in endothelial cells promotes intramembranous ossification via the BMP pathway.Shox2 is essential for the differentiation of cardiac pacemaker cells by repressing Nkx2-5.Arp5 is a key regulator of myocardin in smooth muscle cellsSerum response factor regulates bone formation via IGF-1 and Runx2 signals.Vascular smooth muscle cell in atherosclerosis.Myocardin in biology and disease.The core binding factor CBF negatively regulates skeletal muscle terminal differentiationNotch signaling pathway enhances bone morphogenetic protein 2 (BMP2) responsiveness of Msx2 gene to induce osteogenic differentiation and mineralization of vascular smooth muscle cellsKruppel-like factor 4 contributes to high phosphate-induced phenotypic switching of vascular smooth muscle cells into osteogenic cells.Lowering plasma cholesterol levels halts progression of aortic valve disease in mice.Olfactomedin 2 Regulates Smooth Muscle Phenotypic Modulation and Vascular Remodeling Through Mediating Runt-Related Transcription Factor 2 Binding to Serum Response Factor.p53 negatively regulates the osteogenic differentiation of vascular smooth muscle cells in mice with chronic kidney diseaseVitamin D in Vascular Calcification: A Double-Edged Sword?Systemic Activation of Activin A Signaling Causes Chronic Kidney Disease-Mineral Bone Disorder
P2860
Q24305366-820C5A40-A58D-4680-B2D5-E22604668802Q26827655-17731FCC-542C-4C0B-9EBD-307A98A01DE5Q33952717-C6E27B67-1EDE-43EF-B6C6-1BD115205FE8Q33987854-543B338D-2B20-4EBA-BA98-CE4FE9AE2E0FQ33990996-05BBD3C6-57D6-466C-A9B6-E6DAF3749AA3Q34238391-A093DEC6-A79B-4338-A0FB-8F79D320A45AQ34448785-840AF5BA-7735-44E0-A848-A9A4A57BEA02Q35792795-D13FB2F3-E0CF-497A-9E65-A074EBDC6F01Q35842201-152C1716-1BC2-47BE-AEF2-D042901410B6Q36240998-8275F8CE-29B2-4BFD-B0BF-C0CEEEDB6A78Q36253058-0F59F936-AFE1-4BA9-8B61-37EDA9337779Q36394618-29DD9E1E-2BA3-4DD4-9D4C-EE783AC69464Q36678487-28FA5399-1F65-4B27-95B7-961B89B67AFBQ36917940-9C4DEA2D-182B-4FEC-81D1-C83A283DC6D7Q36974752-AC117A4E-D8E3-4E2C-85C7-62271913B119Q37222054-AEEF55A0-2F8F-4C47-B1BF-D5C5611074FEQ37614849-7C5FEBB8-8812-4A71-9F74-7F3BADDC56E4Q37687505-9810D9D5-FCCA-4B95-8F29-C4FEFCE92165Q38353932-23A0E3B0-F9F3-4066-91FE-568C91BADF5DQ38368573-4B87384E-4B63-4F62-91B3-614868BFEFD7Q39271742-EC7B7229-D722-49A9-B76D-CE2762A885F6Q39563180-A195A9DD-7BE5-4A19-A8D2-F00FE4285866Q41855705-54292053-628D-4C48-90F4-9BA6AB1D7FF2Q41946374-EF977B90-75C2-4DFF-BBFC-5B18A33626C1Q42426487-487D9CA9-20F3-4355-8ADA-B661C5E42F5BQ42539832-6D576AFF-8DE6-4C2E-B083-88E09E155C2FQ54956836-3C2BA2BB-7543-4988-AF32-58B0F1DEC972Q58710472-86F696D8-822F-49E9-8166-43BCB2479804
P2860
Runx2 represses myocardin-mediated differentiation and facilitates osteogenic conversion of vascular smooth muscle cells.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Runx2 represses myocardin-medi ...... vascular smooth muscle cells.
@en
type
label
Runx2 represses myocardin-medi ...... vascular smooth muscle cells.
@en
prefLabel
Runx2 represses myocardin-medi ...... vascular smooth muscle cells.
@en
P2093
P2860
P356
P1476
Runx2 represses myocardin-medi ...... vascular smooth muscle cells.
@en
P2093
Carolina A Yoshida
Hideo Akiyama
Hiroki Matsui
Hiroko Sato
Hiroshi Doi
Keiko Kawai-Kowase
Masahiko Kurabayashi
Masashi Arai
Miki Yamazaki
Takehisa Shimizu
P2860
P304
P356
10.1128/MCB.01771-07
P407
P577
2007-11-26T00:00:00Z